Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

This article was originally published in The Gray Sheet

Executive Summary

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

You may also be interested in...



Industry Perceptions Meet FDA Reality In AdvaMed/Lewin Survey Of 81 Firms

Respondents to 1AdvaMed's first "State of the Medical Technology Industry" survey are holding that "elapsed development times" associated with PMA devices are on the rise, despite FDA data showing shortened or static review times

Industry Perceptions Meet FDA Reality In AdvaMed/Lewin Survey Of 81 Firms

Respondents to 1AdvaMed's first "State of the Medical Technology Industry" survey are holding that "elapsed development times" associated with PMA devices are on the rise, despite FDA data showing shortened or static review times

Warning Letters Needed To Rein In Outlier IVD Practices – Attorney Kahan

The Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) has a new program to deal with certain IVD problems on an "informal" basis, according to OIVD Director Steven Gutman

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017722

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel